Psychotropic Drugs

Includes bibliography, glossary, and an extensive index which cross-references generic and trade names. New editions are available on a subscription basis.

This second edition of the guide features updated information about newer psychotropic agents, as well as new drugs to help manage iatrogenic weight gain, metabolic dysregulation, involuntary movement disorders, and other common problems.

Miller takes readers on an eye-opening tour of psychotropic drugs, describing the various kinds, how they were discovered and developed, and how they have played multiple roles in virtually every culture.

New in this edition:¿ Drugs for ADHD thoroughly revised and updated¿ Antipsychotics with many changes and additions, including fully revised lab tests/monitoring¿ Antidepressants fully revised, including new sections on irreversible MAO-B inhibitor and serotonin modulator and stimulator (SMS), revised frequency of adverse effects table and switching strategies recommendations¿ Hypnotics completely revised¿ Mood stabilizers fully revised and a new toxicity comparison table added¿ Drugs of abuse and treatment of substance use disorder comprehensively revised¿ New unapproved treatments with significant updates, including: anti-inflammatories and NMDA agents in anxiety/OCD, cannabis use, and irritability of autism¿ New agents include: brexpiprazole, cariprazine, hypnotic suvorexant, tasimelteon, vortioxetine¿ New formulations and trade names include: Adasuve, Alprazolam Intensol, Aptensio XR, Aristada, Belbuca, Belsomra, Brintellix, Bunavail, Cotempla XR-ODT, Dyanavel XR, Eldepryl, EMSAM, Evekeo, Hemangeol, Hetlioz, Innopran XL, Invega Trinza, Khedezla, Metadol-D, Mydayis, NyQuil, Quillichew ER, Quillivant XR, Rexulti, Som-Pam, Tegretol (liquid), Trintellix, Versacolz, Vraylar, Vyvanse, Zelapar, ZenzediThe Clinical Handbook of Psychotropic Drugs for Children and Adolescents has become a standard reference and working tool for psychiatrists, pediatricians, psychologists, physicians, pharmacists, nurses, and other mental health professionals.¿ Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions¿) for a quick overview of treatment options¿ Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, nursing implications, and much more - all you need to know for each class of drug¿ Potential interactions and side effects summarized in comparison charts¿ With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek¿ Clearly written patient and caregiver information sheets for download as printable PDF filesThis book is a must for all mental health professionals working with children and adolescents who need an up-to-date, easy-to use, comprehensive summary of all the most relevant information about psychotropic drugs.

This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.

First published in 1998. The purpose of this book is to provide prescribing psychologists and psychology students with an accurate and authoritative reference for psychotropic drugs that are commonly available for clinical prescription in North America. The reference is particularly directed for use by psychologists and psychology students who already have, or are currently developing, their professional expertise and responsibilities in the prescription and management of psychotropic pharmacotherapy as an adjunct to their psychotherapy. The Reference lists detailed drug monographs for over 100 different prescription psychotropic drugs available in North America. Thus, this reference is the most comprehensive psychotropic drug reference for clinical psychologists currently available. Each psychotropic monograph is clearly and concisely written to only reflect essential and important data that are commonly required by prescribing psychologists. Whenever available and appropriate, each monograph includes phonetic pronunciation, up to five common trade or brand names, pharmacologic or therapeutic classification and subclassification, United States Drug Enforcement Agency (USDEA) schedule designation for abuse potential, recommended dosages for adults, children and the elderly, helpful and important notes regarding methods of administration, relative contraindications, clinically significant drug interactions and more. It is hoped that by using the information presented in is book prescribing psychologists and psychology students will be better able to provide their patients with the maximum benefits of adjunctive pharmacotherapy with a minimum of adverse and toxic effects.